Novo Nordisk’s GLP-1 agonist Ozempic has shown efficacy in yet another indication, achieving a 24% reduction in kidney disease-related events in people with type 2 diabetes and chronic kidney disease ...
Read about football news including transfers, results and headlines. Sign up for MailOnline newsletters to get breaking news delivered to your inbox.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results